Efficacy and Safety of Ravulizumab in Adults With Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Interim Analysis From the Ongoing Phase 3 CHAMPION-NMOSD Trial (S38.007)
Year: 2025
Type: article
Source: Neurology
Institutions: Mayo Clinic, The University of Sydney, Technical University of Munich, Hôpitaux Universitaires de Strasbourg, Harvard University, Massachusetts General Hospital, Tohoku Medical and Pharmaceutical University, Universidad Complutense de Madrid, Hospital Clínico San Carlos, John Radcliffe Hospital, Max Delbrück Center, Charité - Universitätsmedizin Berlin, Sapienza University of Rome
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409228249